Access to new tailored cancer therapies and reliable patient information - the challenges

Share :
Published: 17 Mar 2011
Views: 6125
Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna)
In this second of a three part roundtable discussion on the highlights of the Patient Advocacy/Ethics Track at The 2011 Stockholm Cancer Congress, members of the ECCO Patient Advisory Committee discuss treatment in the age of targeted therapies and explain why advancement in tailored cancer therapy and care is so vital. The panellists also explain the new and unique Court Room Trial session, where Patient Information will be put on trial. Complete with a Judge, Prosecutor, Expert Witnesses, Defendant (patient information) and the Congress delegates acting as Jury, this ‘mock’ trial will address the issues surrounding patient information taking a lateral look at health literacy, engaging the audience rather than presenting to it.

Watch the other parts of the discussion:

Battling rare cancers in Europe - access and ethics and Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources